UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 167

Sortiert nach

Use and safety profile of antiepileptic drugs in Italy

European journal of clinical pharmacology, 2007-04, Vol.63 (4), p.409-415

2007

Volltextzugriff (PDF)

Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study

Pharmacoepidemiology and drug safety, 2007-08, Vol.16 (8), p.891-900

2007

Volltextzugriff (PDF)

Nimesulide and renal impairment

European journal of clinical pharmacology, 1999-04, Vol.55 (2), p.151-154

1999

Volltextzugriff (PDF)

Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment

Clinical and experimental rheumatology, 1993-05, Vol.11 (3), p.271

1993

Volltextzugriff (PDF)

Erice Statement 2009: communication, medicines and patient safety

British journal of clinical pharmacology, 2010-02, Vol.69 (2), p.207-208

2010

Volltextzugriff (PDF)

Effects of copper and zinc on proteoglycan metabolism in articular cartilage

Mediators of Inflammation, 1996, Vol.1996 (2), p.95-99

1996

Volltextzugriff (PDF)

Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union

European journal of clinical pharmacology, 1997-09, Vol.52 (6), p.423-427

BELTON, K. J

1997

Volltextzugriff (PDF)

Nongastrointestinal adverse reactions to NSAID

Journal of rheumatology. Supplement, 1990-02, Vol.20, p.42

1990

Volltextzugriff (PDF)

Anti-ulcer activity of carbenoxolone and ISF 3401 on PGE2 release in rat gastric mucosa

Pharmacological research, 1993-02, Vol.27 (2), p.141-150

1993

Volltextzugriff (PDF)

Eicosanoid and gastroprotection by copper derivatives and NDGA

Inflammation research, 1995-03, Vol.44 (3), p.139-142

1995

Volltextzugriff (PDF)

Why Ecopharmacovigilance?

Drug safety, 2007, Vol.30 (10), p.919-990

Velo, G P

2007

Volltextzugriff (PDF)

Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters

Journal of pharmacy and pharmacology, 1983-11, Vol.35 (11), p.757-758

1983

Volltextzugriff (PDF)

Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats

Pharmacological research, 1991, Vol.23 (1), p.51-56

1991

Volltextzugriff (PDF)

Antimicrobial drug utilisation in hospitals in Italy and other European countries

Infection, 1994-01, Vol.22 Suppl 3 (S3), p.S176-S181

1994

Volltextzugriff (PDF)

Distribution of ceftazidime in ascitic fluid

Antimicrobial Agents and Chemotherapy, 1984-06, Vol.25 (6), p.760-763

1984

Volltextzugriff (PDF)

The inhibition of hepatic microsomal drug metabolism in rats by non-steroidal anti-inflammatory drugs

Pharmacological research, 1990-09, Vol.22, p.115-116

1990

Volltextzugriff (PDF)

Oral zinc sulphate as primary therapeutic intervention in a child with Wilson disease

European journal of pediatrics, 1989-06, Vol.148 (7), p.654-655

1989

Volltextzugriff (PDF)

Pharmacokinetics of ceftazidime and ceftriaxone and their penetration into the ascitic fluid

Journal of antimicrobial chemotherapy, 1985-08, Vol.16 (2), p.267-273

1985

Volltextzugriff (PDF)

Two and half years of oral zinc sulphate therapy in an adult patient with wilson's disease

Pharmacological research, 1989-11, Vol.21, p.151-152

1989

Volltextzugriff (PDF)

Copper metabolism during acute inflammation: studies on liver and serum copper concentrations in normal and inflamed rats

British journal of pharmacology, 1983-05, Vol.79 (1), p.45-52

1983

Volltextzugriff (PDF)

Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10-year-old child

Acta Paediatrica, 1992-02, Vol.81 (2), p.163-166

1992

Volltextzugriff (PDF)

Synthesis of prostaglandin E2 in rat liver

Pharmacological research, 1993-12, Vol.28 (4), p.367-374

1993

Volltextzugriff (PDF)

Copper supplementation in the rat: preliminary observations on the clinical, hematological and histopathological profile

Agents and Actions, 1992-01, Vol.Spec No (S1), p.C118-C120

1992

Volltextzugriff (PDF)

Copper and zinc status in adjuvant-arthritic rat: studies on blood, liver, kidneys, spleen and inflamed paws

Agents and Actions, 1988-07, Vol.24 (3-4), p.365-376

1988

Volltextzugriff (PDF)

Erice statement on drug innovation

British journal of clinical pharmacology, 2008-03, Vol.65 (3), p.440-441

2008

Volltextzugriff (PDF)

1 – 25 von 167

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(116)

Publikationsform

Artikel
(162)
Tagungsberichte
(5)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Use and safety profile of antiepileptic drugs in Italy

Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study

Nimesulide and renal impairment

Copper and zinc status in rheumatoid arthritis: studies of plasma, erythrocytes, and urine, and their relationship to disease activity markers and pharmacological treatment

Erice Statement 2009: communication, medicines and patient safety

Effects of copper and zinc on proteoglycan metabolism in articular cartilage

Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union

Nongastrointestinal adverse reactions to NSAID

Anti-ulcer activity of carbenoxolone and ISF 3401 on PGE2 release in rat gastric mucosa

Eicosanoid and gastroprotection by copper derivatives and NDGA

Why Ecopharmacovigilance?

Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters

Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats

Antimicrobial drug utilisation in hospitals in Italy and other European countries

Distribution of ceftazidime in ascitic fluid

The inhibition of hepatic microsomal drug metabolism in rats by non-steroidal anti-inflammatory drugs

Oral zinc sulphate as primary therapeutic intervention in a child with Wilson disease

Pharmacokinetics of ceftazidime and ceftriaxone and their penetration into the ascitic fluid

Two and half years of oral zinc sulphate therapy in an adult patient with wilson's disease

Copper metabolism during acute inflammation: studies on liver and serum copper concentrations in normal and inflamed rats

Oral zinc as initial therapy in Wilson's disease: two years of continuous treatment in a 10-year-old child

Synthesis of prostaglandin E2 in rat liver

Copper supplementation in the rat: preliminary observations on the clinical, hematological and histopathological profile

Copper and zinc status in adjuvant-arthritic rat: studies on blood, liver, kidneys, spleen and inflamed paws

Erice statement on drug innovation

Suchergebnisse filtern